
A study suggests transdermal capillary blood (TCB) collection as a practical alternative for detecting key type 1 diabetes biomarkers. Researchers found TCB sampling to be sensitive and specific for measuring plasma C-peptide, offering a convenient method compared to traditional venous sampling. The study, involving 91 individuals, demonstrated good agreement between TCB and venous plasma measurements. Additionally, TCB was preferred by a majority of participants over venous sampling, indicating its acceptability. Further assessment is needed for TCB sampling in detecting islet autoantibodies.
Like
Save
Share